HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

POLYQUATERNIUM-7 IS SAFE AS USED, CIR CONCLUDES

This article was originally published in The Rose Sheet

Executive Summary

POLYQUATERNIUM-7 IS SAFE AS USED, CIR CONCLUDES in a tentative report issued at the May 23-24 meeting of the Cosmetic Ingredient Review (CIR) expert panel in Vienna, VA. The report had been on hold for two years while the panel waited for results of a dermal sensitization test conducted by industry. The report notes that in the Repeat Insult Patch Test, "no adverse effects were observed in any of the 150 panelists who completed the study." After a 90-day public comment period, a final report may be issued.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel